NBE-THERAPEUTICS.COM SERVER
We revealed that a lone root page on nbe-therapeutics.com took six hundred and twenty-five milliseconds to stream. We could not detect a SSL certificate, so we consider this site not secure.
Internet Protocol
206.188.192.240
BROWSER IMAGE
![](/f/uapfqaotbdwstshzervakgjj/256/nbe-therapeutics.com.png)
SERVER OS
We observed that nbe-therapeutics.com is operating the openresty/1.11.2.4 operating system.HTML TITLE
Antibody drug conjugateDESCRIPTION
NBE therapeutics is speciliced in reserarch for antibody drug conjugates with patent-pending SMACTM-TechnologyPARSED CONTENT
The domain had the following in the site, "NBE-Therapeutics is a privately owned Swiss, Basel-based Biotech company that was founded in 2012 with the vision to develop next-generation ADCs improving treatment options for cancer patients." We observed that the web site stated " It is NBE Therapeutics vision to become a leader in antibody-based drug development by developing its own portfolio of drugs until demonstration of a clinical proof-of-concept in man." It also stated " Basel, 2018-03-05 - USPTO grants US patent for NBE-Therapeutics core conjugation technology." The header had Antibody drug conjugate as the highest ranking keyword.